| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2025-09-30 | 13.66% | -20.42% | -4.72% | 121/132 | 51.53% | 佰仁医疗 | 88.17% | 行业排名> |
| 2025-06-30 | 14.34% | -11.46% | -16.46% | 121/132 | 51.65% | 佰仁医疗 | 88.54% | 行业排名> |
| 2025-03-31 | 17.17% | 17.09% | 4.17% | 117/132 | 51.25% | 佰仁医疗 | 85.72% | 行业排名> |
| 2024-12-31 | 16.48% | 33.97% | -4.03% | 121/132 | 52.33% | 佰仁医疗 | 88.34% | 行业排名> |
| 2024-09-30 | 17.17% | 29.37% | 6.02% | 119/132 | 53.25% | 佰仁医疗 | 88.56% | 行业排名> |
| 2024-06-30 | 16.2% | 34.58% | 10.47% | 121/132 | 53.3% | 佰仁医疗 | 89.27% | 行业排名> |
| 2024-03-31 | 14.66% | 14.48% | 19.19% | 119/132 | 53.43% | 佰仁医疗 | 89.28% | 行业排名> |
| 2023-12-31 | 12.3% | 20.2% | -7.32% | 122/132 | 53.31% | 正海生物 | 89.9% | 行业排名> |
| 2023-09-30 | 13.27% | 31.49% | 10.29% | 117/132 | 54.06% | 正海生物 | 90.39% | 行业排名> |
| 2023-06-30 | 12.03% | 7.41% | -6.04% | 122/132 | 53.45% | 正海生物 | 90.3% | 行业排名> |
| 2023-03-31 | 12.81% | -12.16% | 25.15% | 116/132 | 53.66% | 正海生物 | 89.78% | 行业排名> |
| 2022-12-31 | 10.23% | -78.2% | 1.38% | 124/132 | 53.83% | 三友医疗 | 90.18% | 行业排名> |
| 2022-09-30 | 10.09% | -81.27% | -9.91% | 117/132 | 55.13% | 三友医疗 | 90.14% | 行业排名> |
| 2022-06-30 | 11.2% | -81.76% | -23.15% | 123/132 | 54.78% | 三友医疗 | 90.29% | 行业排名> |
| 2022-03-31 | 14.58% | -78.82% | -68.95% | 109/132 | 56.28% | 三友医疗 | 90.73% | 行业排名> |
| 2021-12-31 | 46.95% | -27.1% | -12.86% | 87/132 | 57.29% | 三友医疗 | 90.5% | 行业排名> |
| 2021-09-30 | 53.88% | -14.23% | -12.31% | 69/132 | 59.17% | 三友医疗 | 90.29% | 行业排名> |
| 2021-06-30 | 61.44% | 14.99% | -10.74% | 59/132 | 58.42% | 正海生物 | 90.78% | 行业排名> |
| 2021-03-31 | 68.83% | 66.67% | 6.88% | 37/132 | 60.75% | 正海生物 | 91.59% | 行业排名> |
| 2020-12-31 | 64.4% | 38.11% | 2.52% | 59/132 | 59.59% | 正海生物 | 92.23% | 行业排名> |
| 2020-09-30 | 62.82% | 36.62% | 17.57% | 45/132 | 61.59% | 正海生物 | 92.69% | 行业排名> |
| 2020-06-30 | 53.43% | 17.7% | 29.38% | 73/132 | 59.94% | 正海生物 | 92.61% | 行业排名> |
| 2020-03-31 | 41.3% | -2.48% | -11.44% | 59/132 | 58.33% | 正海生物 | 94.38% | 行业排名> |
| 2019-12-31 | 46.63% | 14.95% | 1.42% | 78/132 | 56.37% | 正海生物 | 93.12% | 行业排名> |
| 2019-09-30 | 45.98% | 18.55% | 1.29% | 39/132 | 55.22% | 正海生物 | 93.78% | 行业排名> |
| 2019-06-30 | 45.39% | 43.4% | 7.2% | 50/132 | 57.37% | 正海生物 | 93.09% | 行业排名> |
| 2019-03-31 | 42.35% | 57.5% | 4.38% | 32/132 | 52.04% | 正海生物 | 93.85% | 行业排名> |
| 2018-12-31 | 40.57% | 29.2% | 4.6% | 79/132 | 55.53% | 正海生物 | 93.08% | 行业排名> |
| 2018-09-30 | 38.78% | 25.69% | 22.52% | 35/132 | 51.47% | 正海生物 | 92.83% | 行业排名> |
| 2018-06-30 | 31.66% | 4.23% | 17.74% | 49/132 | 51.56% | 正海生物 | 92.44% | 行业排名> |
| 2018-03-31 | 26.89% | -13.51% | -14.37% | 46/132 | 50.98% | 正海生物 | 92.7% | 行业排名> |
| 2017-12-31 | 31.4% | 15.61% | 1.75% | 88/132 | 55.34% | 正海生物 | 93.67% | 行业排名> |
| 2017-09-30 | 30.86% | 6.57% | 1.6% | 42/132 | 52.35% | 正海生物 | 94.14% | 行业排名> |
| 2017-06-30 | 30.37% | 2.18% | -2.29% | 52/132 | 53.87% | 正海生物 | 93.83% | 行业排名> |
| 2017-03-31 | 31.08% | 7.22% | 14.46% | 38/132 | 52.96% | 正海生物 | 93.69% | 行业排名> |
| 2016-12-31 | 27.16% | 4.68% | -6.21% | 73/132 | 56.43% | 正海生物 | 92.79% | 行业排名> |
| 2016-09-30 | 28.96% | 11.27% | -2.58% | 36/132 | 50.39% | 健帆生物 | 84.23% | 行业排名> |
| 2016-06-30 | 29.72% | 20.95% | 2.52% | 43/132 | 51.46% | 明德生物 | 86.71% | 行业排名> |
| 2016-03-31 | 28.99% | 24.02% | 11.76% | 30/132 | 48.15% | 健帆生物 | 83.86% | 行业排名> |
| 2015-12-31 | 25.94% | 66.07% | -0.31% | 57/132 | 53.26% | 正海生物 | 94.02% | 行业排名> |
| 2015-09-30 | 26.02% | 75.49% | 5.89% | 32/132 | 47.96% | 冠昊生物 | 84.57% | 行业排名> |
| 2015-06-30 | 24.58% | 92.42% | 5.13% | 42/132 | 51.86% | 艾德生物 | 94.5% | 行业排名> |
| 2015-03-31 | 23.38% | 81.46% | 49.65% | 33/132 | 48.84% | 基蛋生物 | 85.13% | 行业排名> |

微信公众号
证券之星APP



